-
1
-
-
0021338037
-
Bezafibrate-induced rhabdomyolysis in a patient with reduced renal function
-
Haubenstock A, Schmidt P, Zazgornik J, Balcke P, Kopsa H, Serti K. Bezafibrate-induced rhabdomyolysis in a patient with reduced renal function. Dtsch Med Wochenschr 1984; 109: 157-158
-
(1984)
Dtsch Med Wochenschr
, vol.109
, pp. 157-158
-
-
Haubenstock, A.1
Schmidt, P.2
Zazgornik, J.3
Balcke, P.4
Kopsa, H.5
Serti, K.6
-
2
-
-
0026502596
-
Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria
-
Chan PCK, Robinson JD, Yeung WC, Cheng IKP, Yeung HWD, Tsang MTS. Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria. Nephrol Dial Transplant 1992; 7: 93-99
-
(1992)
Nephrol Dial Transplant
, vol.7
, pp. 93-99
-
-
Chan, P.C.K.1
Robinson, J.D.2
Yeung, W.C.3
Cheng, I.K.P.4
Yeung, H.W.D.5
Tsang, M.T.S.6
-
3
-
-
85047695019
-
Lipoprotein(a) in renal patients: Is it a key factor in the high cardiovascular mortality?
-
Wanner C, Bartens W. Lipoprotein(a) in renal patients: is it a key factor in the high cardiovascular mortality? Nephrol Dial Transplant 1994; 9: 1066-1068
-
(1994)
Nephrol Dial Transplant
, vol.9
, pp. 1066-1068
-
-
Wanner, C.1
Bartens, W.2
-
4
-
-
0020429608
-
Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease
-
Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 1982; 2: 1309-1311
-
(1982)
Lancet
, vol.2
, pp. 1309-1311
-
-
Moorhead, J.F.1
Chan, M.K.2
El-Nahas, M.3
Varghese, Z.4
-
5
-
-
0026644990
-
Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V
-
Biesenbach G, Zazgornik J: Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V, Clin Nephrol 1994; 37: 274-279
-
(1994)
Clin Nephrol
, vol.37
, pp. 274-279
-
-
Biesenbach, G.1
Zazgornik, J.2
-
6
-
-
0023860312
-
Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation
-
letter
-
Tobert JA. Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation. N Engl J Med 1988; 318: 48 (letter)
-
(1988)
N Engl J Med
, vol.318
, pp. 48
-
-
Tobert, J.A.1
-
7
-
-
0025365041
-
Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy
-
Pierce LR, Wysowski DK, Gross TP. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 1990; 264: 71-76
-
(1990)
JAMA
, vol.264
, pp. 71-76
-
-
Pierce, L.R.1
Wysowski, D.K.2
Gross, T.P.3
-
9
-
-
0017069532
-
Acute renal failure due to nontraumatic rhabdomyolysis
-
Koffler A, Friedler RM, Massry SG. Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med 1976; 85: 23-28
-
(1976)
Ann Intern Med
, vol.85
, pp. 23-28
-
-
Koffler, A.1
Friedler, R.M.2
Massry, S.G.3
-
10
-
-
85035180434
-
-
Mevacor (lovastatin, MSD). West Point, Pa: Merck Sharp & Dohme, July 1990, US package circular
-
Mevacor (lovastatin, MSD). West Point, Pa: Merck Sharp & Dohme, July 1990, US package circular
-
-
-
-
11
-
-
0025681216
-
Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin
-
Pan HY, De Vault AR, Wang-Iverson D, Ivashkiv E, Swanson BN, Sugerman AA. Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin. J Clin Pharmacol 1990; 30: 1128-1135
-
(1990)
J Clin Pharmacol
, vol.30
, pp. 1128-1135
-
-
Pan, H.Y.1
De Vault, A.R.2
Wang-Iverson, D.3
Ivashkiv, E.4
Swanson, B.N.5
Sugerman, A.A.6
|